AngioLab (XKRX:251280) Price-to-Operating-Cash-Flow : (As of May. 26, 2024)

View and export this data going back to 2016. Start your Free Trial

What is AngioLab Price-to-Operating-Cash-Flow?

As of today (2024-05-26), AngioLab's share price is ₩6000.00. AngioLab's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-300.10. Hence, AngioLab's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for AngioLab's Price-to-Operating-Cash-Flow or its related term are showing as below:

XKRX:251280's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.275
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

AngioLab's Cash Flow from Operations per share for the six months ended in Dec. 2023 was ₩-300.10. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-300.10.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 46.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 18.90% per year.

During the past 7 years, AngioLab's highest 3-Year average Operating Cash Flow per Share Growth Rate was 46.10% per year. The lowest was -32.00% per year. And the median was 11.20% per year.

AngioLab Price-to-Operating-Cash-Flow Historical Data

The historical data trend for AngioLab's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Price-to-Operating-Cash-Flow Chart

AngioLab Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

AngioLab Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of AngioLab's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, AngioLab's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AngioLab's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AngioLab's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where AngioLab's Price-to-Operating-Cash-Flow falls into.

AngioLab Price-to-Operating-Cash-Flow Calculation

AngioLab's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	6000.00	/	-300.104
	=

AngioLab's Share Price of today is ₩6000.00.
For company reported annually, GuruFocus uses latest annual data as the TTM data. AngioLab's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-300.10.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

AngioLab Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of AngioLab's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN

Website

http://www.angiolab.co.kr

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines